Supplementation of Bacillus sp. DU-106 reduces hypercholesterolemia and ameliorates gut dysbiosis in high-fat diet rats
Authors:
- 31 October 2020
- journal article
- research article
- Published by Springer Nature in Applied Microbiology and Biotechnology
- Vol. 105 (1) , 287-299
Abstract
Gut microbiota modulation by a probiotic is a novel therapy for hypercholesterolemia mitigation. This study initially investigated the potential hypocholesterolemic effect of Bacillus sp. DU-106 in hypercholesterolemic rats and explored its potential relation with gut microbiota. Sprague–Dawley rats received a high-fat diet, or a high-fat diet supplemented with 7.5 × 109 and 1.5 × 1010 CFU/kg bw/day Bacillus sp. DU-106 (low-dose and high-dose groups). At the end of 9 weeks, Bacillus sp. DU-106 treatment significantly decreased the body weight, liver index, and total cholesterol. 16S rRNA sequencing showed that Bacillus sp. DU-106 intervention significantly increased bacterial richness and particularly increased the genus abundance of Turicibacter, Acinetobacter, Brevundimonas, and Bacillus and significantly decreased the abundance of Ralstonia. Metabolomic data further indicated that the supplementation of Bacillus sp. DU-106 remarkably changed the gut metabolic profiles of hypercholesterolemic rats and, in particular, elevated the metabolites of indole-3-acetate, methylsuccinic acid, creatine, glutamic acid, threonine, lysine, ascorbic acid, and pyridoxamine. Spearman’s correlation analysis showed the close relation between the different genera and metabolites. In conclusion, Bacillus sp. DU-106 supplement ameliorated high-fat diet-induced hypercholesterolemia and showed potential probiotic benefits for the intestine. Key points • A novel potential probiotic Bacillus sp. DU-106 ameliorated hypercholesterolemia in rats. • Bacillus sp. DU-106 supplement regulated gut microbiome structure and richness. • Bacillus sp. DU-106 supplement changed metabolic profiles in high-fat diet rats. • Significant correlations were observed between differential genera and metabolites.Keywords
Funding Information
- Guangdong Provincial Introduction of Innovative Research and Development Team (2018B020206001)
- Guangdong Provincial Special Fund for Modern Agriculture Industry Technology Innovation Teams (2019KJ125)
This publication has 76 references indexed in Scilit:
- Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic DiseasesExperimental Diabetes Research, 2012
- Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol dietBMC Complementary and Alternative Medicine, 2011
- The gut microbiota modulates host energy and lipid metabolism in miceJournal of Lipid Research, 2010
- Metabolism and functions of l-glutamate in the epithelial cells of the small and large intestinesThe American Journal of Clinical Nutrition, 2009
- Diet-Induced Metabolic Improvements in a Hamster Model of Hypercholesterolemia Are Strongly Linked to Alterations of the Gut MicrobiotaApplied and Environmental Microbiology, 2009
- Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease RiskJACC, 2009
- Dose- and Glucose-Dependent Effects of Amino Acids on Insulin Secretion from Isolated Mouse Islets and Clonal INS-1E Beta-CellsThe Review of Diabetic Studies, 2008
- Non–High-Density Lipoprotein and Very-Low-Density Lipoprotein Cholesterol and Their Risk Predictive Values in Coronary Heart DiseaseThe American Journal of Cardiology, 2006
- The Acinetobacter outer membrane protein A (OmpA) is a secreted emulsifierEnvironmental Microbiology, 2006
- Non–High-Density Lipoprotein Cholesterol Versus Low-Density Lipoprotein Cholesterol as a Risk Factor for a First Nonfatal Myocardial InfarctionThe American Journal of Cardiology, 2005